Administration-Time Differences in Effects of Hypertension Medications on Ambulatory Blood Pressure Regulation

作者: Ramón C. Hermida , Diana E. Ayala , José R. Fernández , Artemio Mojón , Michael H. Smolensky

DOI: 10.3109/07420528.2012.709448

关键词: CardiologyPerindoprilInternal medicineLisinoprilChronotherapy (sleep phase)BedtimeBlood pressureSpiraprilAmbulatory blood pressureRamiprilEndocrinologyMedicine

摘要: Specific features of the 24-h blood pressure (BP) pattern are linked to progressive injury target tissues and risk cardiovascular disease (CVD) events. Several studies have consistently shown an association between blunted asleep BP decline fatal nonfatal CVD Thus, there is growing focus on ways properly control during nighttime sleep as well daytime activity. One strategy, termed chronotherapy, entails timing hypertension medications endogenous circadian rhythm determinants pattern. Significant clinically meaningful treatment-time differences in beneficial and/or adverse effects at least six different classes medications, their combinations, now known. Generally, calcium channel blockers (CCBs) more effective with bedtime than morning dosing, for dihydropyridine derivatives dosing significantly reduces peripheral edema. The renin-angiotensin-aldosterone system highly rhythmic activates sleep. Accordingly, evening/bedtime ingestion angiotensin-converting enzyme inhibitors (ACEIs) benazepril, captopril, enalapril, lisinopril, perindopril, quinapril, ramipril, spirapril, trandolapril, zofenopril exerts marked effect awake systolic (SBP) diastolic (DBP) means. Likewise, bedtime, comparison morning, schedule angiotensin-II receptor (ARBs irbesartan, olmesartan, telmisartan, valsartan greater therapeutic BP, plus significant increase sleep-time relative decline, additional benefit, independent drug terminal half-life, converting profile into a normal dipping This case also versus upon-awakening regimen combination ARB-CCB, ACEI-CCB, ARB-diuretic medications. chronotherapy conventional constitutes new cost-effective strategy enhancing SBP DBP levels, normalizing status patterning, potentially reducing events end-organ injury, example, vessels heart, brain, kidney, retina.

参考文章(262)
J. Arendt, The Pineal Gland, Circadian Rhythms and Photoperiodism Handbook of experimental pharmacology. ,vol. 125, pp. 375- 414 ,(1997) , 10.1007/978-3-662-09355-9_14
Roberto Fogari, Paola Preti, Annalisa Zoppi, Paola Lusardi, Elena Piazza, Sandra Savino, Effect of bedtime melatonin ingestion on blood pressure of normotensive subjects. Blood Pressure Monitoring. ,vol. 2, pp. 99- 103 ,(1997)
G Nold, B Lemmer, G Strobel, Morning versus evening amlodipine treatment: effect on circadian blood pressure profile in essential hypertensive patients. Blood Pressure Monitoring. ,vol. 3, pp. 17- 25 ,(1998)
Debra J. Skene, Steven W. Lockley, Josephine Arendt, Use of melatonin in the treatment of phase shift and sleep disorders. Advances in Experimental Medicine and Biology. ,vol. 467, pp. 79- 84 ,(1999) , 10.1007/978-1-4615-4709-9_10
Gabriela Angelescu, Elena Popescu, H Bălan, Comparing different treatment schedules of Zomen (zofenopril). Romanian journal of internal medicine = Revue roumaine de médecine interne. ,vol. 49, pp. 75- 84 ,(2011)
Nava Zisapel, Doron Garfinkel, Ehud Grossman, Moshe Laudon, Michael Jonas, Impaired nocturnal melatonin secretion in non-dipper hypertensive patients. Blood Pressure. ,vol. 12, pp. 19- 24 ,(2003)
Yuan-Gang Qiu, Jun-Zhu Chen, Jian-Hua Zhu, Xue-Yan Yao, Differential Effects of Morning or Evening Dosing of Amlodipine on Circadian Blood Pressure and Heart Rate Cardiovascular Drugs and Therapy. ,vol. 17, pp. 335- 341 ,(2003) , 10.1023/A:1027347723347
B. Lemmer, F. Portaluppi, Chronopharmacology of Cardiovascular Diseases Handbook of experimental pharmacology. ,vol. 125, pp. 251- 297 ,(1997) , 10.1007/978-3-662-09355-9_10
P Mormino, M Del Torre, A C Pessina, L Mos, P Palatini, L Varotto, M Motolese, E Pavan, Effect of evening versus morning benazepril on 24-hour blood pressure : a comparative study with continuous intraarterial monitoring International journal of clinical pharmacology, therapy, and toxicology. ,vol. 31, pp. 295- 300 ,(1993)